Mary Wilson
Well-known member
The European Medicines Agency (EMA) is closely monitoring the outbreak of monkeypox in Europe. It is in close contact with medicine developers and its partner organisations in the European Union (EU) to make medicines to prevent and treat monkeypox available to patients in the EU
... EMA's Emergency Task Force (ETF) is looking into available treatment options and other measures to combat the monkeypox outbreak. These include facilitating clinical trials and working with EU partners.
Potential medicines against monkeypox
Tecovirimat
There is one antiviral treatment against monkeypox authorised in the EU, Tecovirimat.
Tecovirimat is also authorised to treat smallpox and cowpox.
Imvanex
There is a vaccine that could potentially be used to prevent monkeypox, Imvanex.
Imvanex is already authorised to prevent smallpox in the EU. ...
ETF statement on monkeypox vaccine
In the United States, the vaccine is available under the brand name Jynneos. It is already authorised to prevent both smallpox and monkeypox.
As there are currently limited supplies of Imvanex in the EU, EMA's ETF is recommending that Jynneos can be used to prevent monkeypox.
... ETF has given this advice to support national authorities who may decide, as a temporary measure, to import Jynneos from the US to help tackle the rising rates of infection.
https://www.ema.europa.eu/en/human-...potential-medicines-against-monkeypox-section
... EMA's Emergency Task Force (ETF) is looking into available treatment options and other measures to combat the monkeypox outbreak. These include facilitating clinical trials and working with EU partners.
Potential medicines against monkeypox
Tecovirimat
There is one antiviral treatment against monkeypox authorised in the EU, Tecovirimat.
Tecovirimat is also authorised to treat smallpox and cowpox.
Imvanex
There is a vaccine that could potentially be used to prevent monkeypox, Imvanex.
Imvanex is already authorised to prevent smallpox in the EU. ...
ETF statement on monkeypox vaccine
In the United States, the vaccine is available under the brand name Jynneos. It is already authorised to prevent both smallpox and monkeypox.
As there are currently limited supplies of Imvanex in the EU, EMA's ETF is recommending that Jynneos can be used to prevent monkeypox.
... ETF has given this advice to support national authorities who may decide, as a temporary measure, to import Jynneos from the US to help tackle the rising rates of infection.
https://www.ema.europa.eu/en/human-...potential-medicines-against-monkeypox-section